Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
Venture Capital in Biotechnology
Matherne, G. (Paul); Herpfer, Christoph; Dow, EthanNota técnica DARDEN-OM-1796-EServicios y operacionesPharmaceutical companies have historically relied on their ability to research, develop, manufacture, and sell drug products. Developing a successful drug is a complex and lengthy process, with no guarantee of success, and the total cost of approving a new drug is estimated at $2.5 billion, and rising. This technical note offers an overview of changes in the biotechnology industry related to drug development, focusing on M&A, the milestone model,...Desde 8,20 €
-
Venture Capital in Biotechnology
Matherne, G. (Paul); Herpfer, Christoph; Dow, EthanNota técnica DARDEN-OM-1796Servicios y operacionesPharmaceutical companies have historically relied on their ability to research, develop, manufacture, and sell drug products. Developing a successful drug is a complex and lengthy process, with no guarantee of success, and the total cost of approving a new drug is estimated at $2.5 billion, and rising. This technical note offers an overview of changes in the biotechnology industry related to drug development, focusing on M&A, the milestone model,...Desde 8,20 €